Buchheidt 2004.
Study characteristics | |||
Patient sampling | Study design not clear. Episode‐based analysis | ||
Patient characteristics and setting | 177 participants
Age ranged from 17 to 81 years
Germany
No further info Adults with haematological malignancies undergoing chemotherapy or bone marrow transplantation and fulfilled host factor criteria (Ascioglu 2002) Inpatients Representative spectrum? Unclear: selection process not clearly reported |
||
Index tests | Platelia: positivity was defined as 2 or more serial samples with ODI > 1.5 times the cut‐off index and with > 0.7 times the cut‐off index. On average every 3 days samples were measured | ||
Target condition and reference standard(s) | Invasive aspergillosis, according to EORTC criteria (Ascioglu 2002) Incorporation avoided? Not reported Acceptable reference standard? Yes: all assays were evaluated for sensitivity and specificity in the detection of IA after classification of patient episodes according to the 2002 guidelines established by the EORTC/MSG (Ascioglu 2002) |
||
Flow and timing | Time interval: not reported Partial verification avoided? Yes: all assays were evaluated for sensitivity and specificity in the detection of IA after classification of patient episodes according to the 2002 guidelines established by the EORTC/MSG (Ascioglu 2002) Withdrawals explained? No Uninterpretable results reported? No |
||
Comparative | |||
No patients per category | 6 proven, 3 probable, 75 possible, 93 non‐IA | ||
Notes | Sponsoring? Funded by the German Jose Carreras Leukemia Fund | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Unclear | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Unclear |